Humacyte, Inc. HUMA
0.56
(0.01)
(1.75%)
as of 25 Sep
- Market cap
- $166.7M
- P/E
- 0.0×
Follow HUMA
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
P/S ratio |
74.50 | — | — | 138.94 | 229.44 | 0.00 | — | — |
P/FCF ratio |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
P/Operating CF |
(5.81) | — | — | (11.47) | (13.51) | (462.70) | — | — |
P/B ratio |
48.84 | — | — | 1.86 | 2.37 | 1.13 | — | — |
Price to Tangible BV |
48.84 | — | — | 1.86 | 2.37 | 1.13 | — | — |
EV/Sales |
81.59 | — | — | 73.88 | 90.88 | 0.00 | — | — |
EV/EBITDA |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
(1.58) | — | — | (1.63) | (1.41) | 0.00 | — | — |
EV/FCF |
(1.57) | — | — | (1.60) | (1.41) | 0.00 | — | — |
Quick Ratio |
2.77 | 2.25 | 4.36 | 7.76 | 20.42 | 3.56 | — | — |
Current Ratio |
3.69 | 2.40 | 4.52 | 7.88 | 20.75 | 3.69 | — | — |
Net Debt/EBITDA |
(0.12) | 0.29 | 0.70 | 1.51 | 2.46 | 0.30 | — | — |
Debt/Assets |
53.64% | 9.88% | 12.71% | 19.18% | 16.92% | 21.64% | 0.00% | 0.00% |
Debt/Equity |
20.08 | (0.26) | 1.20 | 0.34 | 0.40 | (0.07) | — | — |
Asset Turnover |
0.02 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.00 | — |
Operating CF/Net income |
2.57 | 0.66 | 0.66 | 5.94 | 3.07 | 0.84 | — | — |
Capex/Depreciation |
(0.12) | (0.22) | (0.28) | (0.11) | (0.02) | (0.03) | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| 164.78% | 760.17% | (169.81%) | (10.01%) | 23.21% | 58.32% | — | — | |
| (32.12%) | (111.77%) | (66.63%) | (4.88%) | (13.47%) | (124.71%) | 0.00% | — | |
ROIC |
(449.67%) | 0.00% | 0.00% | (1,247.32%) | 0.00% | 0.00% | — | — |
Return on Tangible Assets |
(60.08%) | (291.75%) | (120.90%) | (7.27%) | (10.45%) | (93.44%) | — | — |
Average Days of Receivables |
78.98 | — | — | 7.23 | 50.86 | 27.66 | — | — |
Research and Development Expense of Revenue |
3,400.49% | 0.00% | 0.00% | 4,042.17% | 4,856.77% | 3,626.96% | — | — |
Selling, General and Administrative Expense of Revenue |
1,529.49% | 0.00% | 0.00% | 1,462.17% | 1,673.00% | 805.70% | — | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
478.56% | 0.00% | 0.00% | 395.14% | 803.33% | 314.82% | — | — |
Graham Net Nets |
(0.30) | — | — | 0.31 | 0.22 | (0.07) | — | — |
Graham Number |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
Earnings Yield |
(20.83%) | — | — | (5.69%) | (91.86%) | (0.20%) | — | — |
Free Cash Flow Yield |
(69.76%) | — | — | (33.19%) | (28.09%) | 0.00% | — | — |
Revenue per Share |
0.01 | 0.00 | 0.00 | 0.02 | 0.03 | 0.26 | — | — |
Operating CF per Share |
(0.66) | (0.83) | (0.71) | (0.69) | (2.03) | (9.64) | — | — |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.01) | (0.01) | (0.05) | — | — |
Free Cash Flow per Share |
(0.67) | (0.84) | (0.73) | (0.70) | (2.04) | (9.68) | — | — |
Cash per Share |
0.32 | 0.38 | 0.78 | 1.47 | 5.64 | 6.93 | — | — |
Shareholders Equity per Share |
0.02 | (0.44) | 0.13 | 1.13 | 3.06 | (60.76) | — | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Book value per Share |
0.02 | (0.44) | 0.13 | 1.13 | 3.06 | (60.76) | — | — |
Free Cash Flow |
(105.93) | (99.69) | (75.58) | (72.18) | (81.41) | (55.84) | — | — |
Working Capital |
49.42 | 27.91 | 64.84 | 134.63 | 218.29 | 30.22 | — | — |
Capital Expenditures |
(0.88) | (1.57) | (2.28) | (1.05) | (0.22) | (0.27) | — | — |
Net Current Asset Value |
(45.46) | (142.68) | (31.40) | 66.83 | 64.98 | (415.56) | — | — |
EV/EBIT |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.43 | 0.00 | 0.00 | 0.67 | 0.17 | 0.18 | — | — |
Net Profit Margin |
(2,003.58%) | 0.00% | 0.00% | (764.54%) | (2,096.36%) | (4,461.70%) | — | — |
Price to Operating Income |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.40 | 0.31 | 0.31 | 0.32 | 0.26 | 0.20 | — | — |
Cash ROIC |
(106.52%) | (2,058.17%) | (90.76%) | (32.85%) | (29.34%) | 33.60% | — | — |
Accounts Receivable Turnover |
8.64 | — | — | 15.12 | 8.74 | 10.32 | — | — |
Accounts Payable Turnover |
1.96 | 0.00 | 0.00 | 4.48 | 3.79 | 3.86 | — | — |
Inventory Turnover |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
203.30 | 0.00 | 0.00 | 70.52 | 92.27 | 98.44 | — | — |
Days of Inventory on Hand |
511.23 | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Receivables |
0.24 | — | — | 0.10 | 0.14 | 0.14 | — | — |
Average Payables |
4.95 | 5.49 | 4.04 | 1.84 | 2.18 | 2.18 | — | — |
Average Assets |
127.12 | 133.05 | 166.26 | 245.42 | 196.61 | 53.34 | 0.00 | — |
Average Common Equity |
(24.78) | (19.56) | 65.24 | 119.55 | (114.07) | (114.07) | — | — |
Columns are period end dates